Market Focus Target audiences include hospitals, cardiology and pulmonology departments, integrated delivery networks, and home health/RPM providers. Pitch pilots and implementation studies for respiratory failure, COPD, and CHF. Position as a complement to existing RPM and telehealth platforms, with daily chest assessments via a chest patch or handheld device.

Value Proposition Frame ROI around reduced hospitalization and improved therapy adherence. Build care-pathway pilots focusing on CHF and COPD, collecting real-world outcomes to support payer negotiations and value-based care programs.

Go To Market With a small team, pursue channel partnerships with DME distributors, medical device manufacturers, and remote patient monitoring platforms. Integrate with common EHR systems and ensure HIPAA-compliant data handling. Use AWS to support scalable analytics and secure cloud hosting.

Technology Differentiation Key differentiators include non-invasive RF microwave radar, two form factors (chest patch and handheld), and AI analytics supporting both diagnostic and therapeutic workflows. Patent-backed tech can help with IP protection and vendor discussions. Emphasize ease of use, home monitoring, and clinical workflow integration.

Market Trends Market trends point to rising demand for digital therapeutics and RPM in chronic respiratory and heart diseases, along with a shift to value-based care. Position LifeWave Biomedical to align with hospital outcomes programs, payor initiatives, and potential partnerships with pharma or device ecosystems seeking to boost adherence and remote management.